- Home
- UTHR vs LNT Comparison
UTHR vs LNT Comparison
Compare UTHR & LNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- LNT
- Stock Information
- Founded
- UTHR 1996
- LNT 1917
- Country
- UTHR United States
- LNT United States
- Employees
- UTHR N/A
- LNT N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- LNT Power Generation
- Sector
- UTHR Health Care
- LNT Utilities
- Exchange
- UTHR Nasdaq
- LNT Nasdaq
- Market Cap
- UTHR 16.2B
- LNT 15.6B
- IPO Year
- UTHR 1999
- LNT N/A
- Fundamental
- Price
- UTHR $359.23
- LNT $58.93
- Analyst Decision
- UTHR Buy
- LNT Buy
- Analyst Count
- UTHR 14
- LNT 7
- Target Price
- UTHR $370.86
- LNT $62.93
- AVG Volume (30 Days)
- UTHR 313.6K
- LNT 1.5M
- Earning Date
- UTHR 02-19-2025
- LNT 02-13-2025
- Dividend Yield
- UTHR N/A
- LNT 3.26%
- EPS Growth
- UTHR 25.10
- LNT N/A
- EPS
- UTHR 22.72
- LNT 2.57
- Revenue
- UTHR $2,756,200,000.00
- LNT $3,966,000,000.00
- Revenue This Year
- UTHR $26.32
- LNT $5.19
- Revenue Next Year
- UTHR $10.37
- LNT $2.93
- P/E Ratio
- UTHR $15.82
- LNT $22.91
- Revenue Growth
- UTHR 25.04
- LNT N/A
- 52 Week Low
- UTHR $208.62
- LNT $46.80
- 52 Week High
- UTHR $417.82
- LNT $64.19
- Technical
- Relative Strength Index (RSI)
- UTHR 43.90
- LNT 37.79
- Support Level
- UTHR $358.82
- LNT $57.89
- Resistance Level
- UTHR $383.00
- LNT $60.94
- Average True Range (ATR)
- UTHR 9.97
- LNT 0.87
- MACD
- UTHR -0.80
- LNT -0.40
- Stochastic Oscillator
- UTHR 29.51
- LNT 21.10
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About LNT Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electric customers and 425,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.